AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do not address the multiple inflammatory pathways that cause its specific symptoms.

Barclays raised the firm’s price target on Johnson & Johnson to $166 from $159 and keeps an Equal Weight rating on the shares. The company

The Magic need perimeter scoring. They're on track to be the worst three-point shooting team in more than a decade and their offensive rating has been stuck in the NBA's bottom third since 2011-12. Complementing Banchero, Wagner and Suggs now could further open Orlando's window of contention.

Dennis Allen—who was introduced as Chicago's next defensive coordinator at a press conference on Thursday—revealed that Johnson reached out to him during the season to see if he'd like to join forces at his next destination.

Read here for an update on Yacktman Asset Management's portfolio changes, top holdings, and performance compared to market indexes.

Hospitals in Colorado, Virginia and the nation’s capital say they have paused gender-affirming care for young people as they evaluate President Donald Trump’s executive order aimed at cutting federal support for such care.

The case against a former district attorney took a blow as a police supervisor testified the accused prosecutor never obstructed her during the investigation of Ahmaud Arbery's murder.

Following Thursday's special session events, Johnson spoke. Dick Button, Olympic skating champion and TV analyst, dies at 95 Warren Buffett: 10 Things Poor People Waste Money On Tulsi Gabbard receives a round of applause upon the conclusion of her hearing

Think about it: Wanders can also mean people using wands. TSA agents use wands to search travelers for prohibited items. For more information on these devious clues, scroll down to “Cracking the Harder Clues” in our free guide on “ How to Solve the New York Times Crossword .”

House Speaker Mike Johnson said he'd be willing to negotiate with Democrats to raise the debt ceiling, something President Donald Trump has said he wants to get rid of entirely.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.  “Today’s approval is